The states with the most international purchases in 2016 were Ciudad de México (US$1.83k).
The main commercial origins of Meprobamate "Inn" in 2016 were India (US$1.83k).
In the global context, the main exporting countries of Meprobamate "Inn" in 2022 were China (US$3.74M), Belgium (US$2.1M), and Germany (US$1.57M). In the same year, the main importing countries of Meprobamate "Inn" were India (US$1.96M), South Africa (US$1.91M), and Ireland (US$1.84M).
The visualizations show the net balance of Meprobamate "Inn" at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
In October 2016, international sales of Meprobamate "Inn" were US$0, while international purchases reached US$1.84k. The above results in a trade balance of -US$1.84k.
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Meprobamate "Inn" and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Meprobamate "Inn". On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Meprobamate "Inn". In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Meprobamate "Inn" were China (US$3.74M), Belgium (US$2.1M), and Germany (US$1.57M). In the same year, the main importing countries for Meprobamate "Inn" were India (US$1.96M), South Africa (US$1.91M), and Ireland (US$1.84M).